Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour Treating Fields for mesothelioma.
Barbarino M, Bottaro M, Luzzi L, Giordano A, Mutti L. Barbarino M, et al. Among authors: mutti l. Lancet Oncol. 2020 Jan;21(1):e8. doi: 10.1016/S1470-2045(19)30829-0. Lancet Oncol. 2020. PMID: 31908312 No abstract available.
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach.
Barbarino M, Cesari D, Bottaro M, Luzzi L, Namagerdi A, Bertolino FM, Bellan C, Proietti F, Somma P, Micheli M, de Santi MM, Guazzo R, Mutti L, Pirtoli L, Paladini P, Indovina P, Giordano A. Barbarino M, et al. Among authors: mutti l. J Cell Mol Med. 2020 May;24(10):5565-5577. doi: 10.1111/jcmm.15213. Epub 2020 Apr 17. J Cell Mol Med. 2020. PMID: 32301278 Free PMC article.
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
Correale P, Saladino RE, Giannarelli D, Sergi A, Mazzei MA, Bianco G, Giannicola R, Iuliano E, Forte IM, Calandruccio ND, Falzea AC, Strangio A, Nardone V, Pastina P, Tini P, Luce A, Caraglia M, Caracciolo D, Mutti L, Tassone P, Pirtoli L, Giordano A, Tagliaferri P. Correale P, et al. Among authors: mutti l. Cells. 2020 Aug 25;9(9):1964. doi: 10.3390/cells9091964. Cells. 2020. PMID: 32854442 Free PMC article.
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
Costa C, Indovina P, Mattioli E, Forte IM, Iannuzzi CA, Luzzi L, Bellan C, De Summa S, Bucci E, Di Marzo D, De Feo M, Mutti L, Pentimalli F, Giordano A. Costa C, et al. Among authors: mutti l. Cell Death Dis. 2020 Sep 14;11(9):748. doi: 10.1038/s41419-020-02940-w. Cell Death Dis. 2020. PMID: 32929059 Free PMC article.
Is There Already a Need of Reckoning on Cancer Immunotherapy?
Correale P, Pentimalli F, Baglio G, Krstic-Demonacos M, Saladino RE, Giordano A, Mutti L. Correale P, et al. Among authors: mutti l. Front Pharmacol. 2021 Mar 26;12:638279. doi: 10.3389/fphar.2021.638279. eCollection 2021. Front Pharmacol. 2021. PMID: 33841155 Free PMC article. No abstract available.
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade.
Nardone V, Giannicola R, Bianco G, Giannarelli D, Tini P, Pastina P, Falzea AC, Macheda S, Caraglia M, Luce A, Zappavigna S, Mutti L, Pirtoli L, Giordano A, Correale P. Nardone V, et al. Among authors: mutti l. Front Oncol. 2021 Jun 14;11:684110. doi: 10.3389/fonc.2021.684110. eCollection 2021. Front Oncol. 2021. PMID: 34195086 Free PMC article.
178 results